Abstract

PostScription: Stopping Drug Reps at the Door

Author(s): Brewer Benjamin

Issue: Jan/Feb 2006 - Sports Medicine

View All Articles in Issue

Page(s): 80

Download in electronic PDF format for $75

Abstract

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2006 Pg. 80	PostScription: Stopping Drug Reps at the Door Author(s): Brewer Benjamin
Mar/Apr 2011 Pg. 117-122	The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding Author(s): Conroy Mary Schaeffer
Nov/Dec 2011 Pg. 526-527	PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Author(s): Williams LaVonn A
Jul/Aug 2012 Pg. 350-351	PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Author(s): Allen Loyd V Jr, Williams LaVonn A
May/Jun 2014 Pg. 262-263	PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry Author(s): Bastos Dea
Jul/Aug 2005 Pg. 293-298	Local Ventilation for Safe Containment in the Pharmaceutical Industry Author(s): Walters Douglas B, Ryan Ray
May/Jun 2000 Pg. 196-197	Cellulose Applications for the Pharmaceutical Industry Author(s): Nicoll Harold
Jul/Aug 2025 Pg. 301-309	Calendula: General Aspects, Applications, and Formulations in the Pharmaceutical Industry Author(s): Molina Jorge Andrés Pacheco, Gutierrez Arlene Loría, Barrantes Jeimy Blanco, Brenes Daniela Matarrita, Muñoz Maripaz Santamaría, Redondo German Madrigal
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Jul/Aug 2007 Pg. 350-351	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 351	PostScription: Responsibilities of a Compounding Pharmacist Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 30-36	Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Author(s): Dillon L R
Nov/Dec 2009 Pg. 574	PostScription: Compounding Seminar: International Pharmaceutical Federation Congress--Istanbul Author(s): Padilla Rafael
Sep/Oct 2007 Pg. 438-439	PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 456-460	Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Author(s): Lyon Joanna
Mar/Apr 2022 Pg. 100-109	Allowing Compounding Pharmacies to Address Drug Shortages Author(s): Broughel James
Mar/Apr 2018 Pg. 108-121	Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun